FTC Nominees Open To Reviewing Past PBM Mergers; Simons Wants Task Force To Monitor Drug Prices

By Michelle M. Stein / February 16, 2018 at 7:16 PM
House and Senate lawmakers worry about the effects of pharmacy benefit manager consolidation, and nominees to the Federal Trade Commission said they expect FTC to review past PBM mergers. At a hearing on their nominations, nominees said health care industries are a priority area, and FTC Chair-nominee Joseph Simons wants to create a task force that monitors drug prices. At a House Energy & Commerce oversight hearing on Wednesday (Feb. 14), subcommittee Vice Chair Morgan Griffith (R-VA) and ranking Democrat...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.